Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
1.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies02:49

Cancer Therapies

8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Forced Transdifferentiation01:28

Forced Transdifferentiation

1.5K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Multidimensional Optimization of Small Bowel Capsule Endoscopy With Transcutaneous Electrical Acustimulation: A Randomized Controlled Trial.

Journal of digestive diseases·2026
Same author

Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α)-induced differentiation therapy for hepatocellular carcinoma.

Journal of digestive diseases·2024
Same author

Reinfection and Risk Factors of SARS-CoV-2 during an Omicron Wave 2022 in Shanghai.

Biomedical and environmental sciences : BES·2024
Same author

Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis.

Journal of digestive diseases·2023
Same author

Prevalence and risk factors of covert hepatic encephalopathy in cirrhotic patients: A multicenter study in China.

Journal of digestive diseases·2023
Same author

Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice.

Journal of digestive diseases·2023
Same journal

Retention of a Patency Capsule Shell in a Nonsteroidal Anti-Inflammatory Drug-Induced Small-Bowel Stricture, Detected and Retrieved by Balloon-Assisted Enteroscopy: Emphasizing the Importance of Confirming Capsule Excretion.

Journal of digestive diseases·2026
Same journal

Pancreatic Tuberculosis Complicated With Duodenal Bulb Fistula Mimics Walled-Off Necrosis: A Case Report.

Journal of digestive diseases·2026
Same journal

Comparison of Tacrolimus and Infliximab for Acute Severe Ulcerative Colitis in Hospitalized Adults: A Retrospective Study.

Journal of digestive diseases·2026
Same journal

Postoperative Clinical Features of High-Grade Squamous Intraepithelial Neoplasia Dominated by Cytological Atypia After Endoscopic Submucosal Dissection.

Journal of digestive diseases·2026
Same journal

Emerging Concepts in the Prevention and Treatment of Severe Acute Pancreatitis.

Journal of digestive diseases·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

7.5K

Differentiation therapy for solid tumors.

Wen Ping Xu1, Xin Zhang, Wei Fen Xie

  • 1Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, China.

Journal of Digestive Diseases
|December 31, 2013
PubMed
Summary
This summary is machine-generated.

Differentiation therapy uses cell differentiation to treat tumors. While successful for acute promyelocytic leukemia (APL), it remains challenging for solid tumors, though new research offers hope.

Keywords:
differentiation therapyepigeneticsneoplastic stem cellsolid tumortranscription factor

More Related Videos

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

8.9K
Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
12:47

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

18.2K

Related Experiment Videos

Last Updated: May 4, 2026

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

7.5K
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

8.9K
Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
12:47

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

18.2K

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Therapeutics

Background:

  • Differentiation therapy induces cancer cell maturation, halting proliferation.
  • All-trans retinoic acid (ATRA) is effective for acute promyelocytic leukemia (APL).
  • Solid tumor differentiation therapy has shown limited success to date.

Purpose of the Study:

  • To review the current status of differentiation therapy for solid tumors.
  • To highlight recent advancements in understanding differentiation pathways.
  • To discuss the potential of novel differentiation-inducing agents.

Main Methods:

  • Literature review of differentiation therapy applications.
  • Analysis of current research on cancer cell differentiation.
  • Evaluation of emerging differentiation-inducing agents.

Main Results:

  • ATRA's success in APL serves as a benchmark.
  • Significant challenges persist in applying differentiation therapy to solid tumors.
  • Recent progress in molecular biology offers new therapeutic avenues.

Conclusions:

  • Differentiation therapy holds promise for solid tumors.
  • Further research into differentiation pathways and agents is crucial.
  • Novel approaches may overcome current limitations in treating solid malignancies.